Navigation Links
Baylor Health Care System Receives National Information Technology Recognition
Date:10/18/2007

DALLAS, Oct. 18 /PRNewswire-USNewswire/ -- This year, Baylor Health Care System ranked 15th on the 2007 Information Week 500 list, a multi-industry ranking that tracks information technology providers across the country. No other health care system ranked higher nationally.

"Since innovation is one the Baylor Health Care System's values, it's gratifying to have an external party recognize us for living our values," says David Muntz, senior vice president and chief information officer, Baylor Health Care System. "We see innovation as a way to deliver better value to our stakeholders, in this case the physicians and their patients."

Baylor's essay responses on the application helped make the organization stand out. One essay focused on the development of a referring physician portal, which allows non-Baylor physicians to refer patients to Baylor facilities. The referring physician has secured access to their patient's electronic medical records, so that they can stay informed about the course of the patient's treatment.

"Being able to provide physicians with a tool which helps deliver information to them on a timely basis helps everyone involved in the care process, particularly the patient," states Muntz. "There's not a day that goes by where we don't think or talk about the portal and the importance of its role in delivering quality and safe care."

The second essay described Baylor's use of radio frequency identification device (RFID) in automating medical device and supply management.

Baylor's focus on new project versus maintenance, deployment of encryption, adoption of Web technologies, including integrating tools from other search companies and a focus on collaboration to increase productivity, all contributed to earning a number 15 ranking.

For 19 years, the Information Week 500 has tracked the most innovative business technology organizations. To be ranked, companies with at least $500 million in annual revenue
'/>"/>

SOURCE Baylor Health Care System
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Startling Expose – Physicians Often Have No Regular Source Of Health Car
3. Debate Rages over firing of HIV infected health care workers
4. Want a Healthy brew? Have some Tea!
5. Patient’s perception of health status helps in better recover
6. Antioxidants protect health tissue in people undergoing radiation therapy.
7. Sexual abuse affect health for a lifetime
8. Smoking a greater risk than HIV? Yes say health experts!!!!
9. Healthcare sector is now a multi billion-dollar industry in India
10. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
11. How much can exercise improve health?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...cal trials presented by Calpis Co., Ltd. at the Am...Annual Scientific Meeting and Exposition (ASH 2008...y supplement AmealPeptide reduces blood pressure i...D (Achieve Hypertension Efficacy with AmealPeptide...tive, Two-phase Randomized, Open-Label, Blinded En...
(Date:5/16/2008)... -- Superior launch strategies,allow best-in-class...,crowded markets. To secure "share of voice" for a...ptake strategies to support business needs and,ens...l companies achieve,attention in the market during...., "Best Practices for Winning Product Launch Suc...
(Date:5/16/2008)...d Information Technology That, Optimizes Cardiolo...ases Efficiency, SE...ced clinical and,information technology (IT) for t...www.siemens.com/healthcare ) will demonstrate the ...iology and cardiology workflow and image,processin...
(Date:5/16/2008)...PRNewswire-FirstCall/ -- BMP,Sunstone Corporation ...and,distribution pharmaceutical companies, today a...owing conferences:, (1) The Roth Annual China D...David Gao, Chief Executive Officer of the Company,... 2008, at 4:40 pm local time at the Regent Ho...
Breaking Medicine News(10 mins):Health News:Calpis' AmealPeptide lowers blood pressure in 2 placebo-controlled trials 2Health News:Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes 2Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 2Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 3Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 4Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 5Health News:BMP Sunstone Announces Participation in May Investor Conferences 2
...equires continuing medical care and patient self-m... and to reduce the risk of long-term complications...r, primary care practitioners are confronted with ...th signs of diabetic nephropathy. Undiagnosed chro...
...ient myth that coco bean can be used to treat diar...n chemicals that can limit the development of flui...t diarrhea dates back to as early as 16th century ...ultures. Until now, very little has been known reg...
... become very easy and cheap compared to other coun...of clinical research to India. Outsourcing in the...cs and development of India, but Outsourcing in /...India, as humans are becoming a source of experime...
...ied women is having more trouble due to her sexual... women and the report finds out that single men is...n compared to married women. // Catherine Mercer...r for Sexual Health and HIV, said. "That is, withi...
Other Medicine News:
(Date:5/16/2008)...Newswire-FirstCall/ -- Pulmo BioTech Inc. (OTC,Bul... methodology and,purpose of its Phase I Human Tria... for the diagnosis of Pulmonary Embolism and Pulmo...by the Pulmo BioTech subsidiary,PulmoScience Inc....the Use,of PulmoBind for Molecular Imaging of the ...
(Date:5/16/2008)...ay 16 /- Data from three studies,eval...moglobin (Hb) levels,and the rate of blood transfu...ons on reimbursement for erythropoiesis-stimulatin...,s blood supply, will be presented at the,American...g later this,month. The meeting will take place in...
(Date:5/16/2008)...bles First-Ever PEGylation of a Small Molecule wit...ity, SAN CARLOS, Calif., May 16 /PRNewswire-First...unced initial results today from a Phase 1,study o...significant,anti-tumor activity in patients with r...s that Nektar,s small molecule PEGylation technolo...
(Date:5/16/2008)...Dual Mechanism May Offer Novel Approach to Blood ...ORLEANS, May 16 /- Pharmaco... and development of novel small,molecule therapeut...lass,Dual Acting Receptor Antagonist (DARA), showe...ons in a Phase 2a study in patients with mild to,m...
Breaking Medicine Technology:Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 4New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 5New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 6Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Alticors 2007 Global Sales Top 247 Billion 11136 1Alticors 2007 Global Sales Top 247 Billion 11136 2Alticors 2007 Global Sales Top 247 Billion 11136 3Alticors 2007 Global Sales Top 247 Billion 11136 4Alticors 2007 Global Sales Top 247 Billion 11136 5Alticors 2007 Global Sales Top 247 Billion 11136 6Shengtai Pharmaceutical Inc Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008 3072 1Shengtai Pharmaceutical Inc Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008 3072 2Shengtai Pharmaceutical Inc Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008 3072 3AstraZeneca Gives 241 5 million to Support North Carolina Worksite Wellness Project 11133 1AstraZeneca Gives 241 5 million to Support North Carolina Worksite Wellness Project 11133 2AstraZeneca Gives 241 5 million to Support North Carolina Worksite Wellness Project 11133 3HMS Holdings Corp Hosts Fourth Quarter and Full Year 2007 Financial Teleconference and Presentation 11130 1HMS Holdings Corp Hosts Fourth Quarter and Full Year 2007 Financial Teleconference and Presentation 11130 2
...SS WIRE)--Jul 9, 2007 - ZIOPHARM,Oncology, Inc. (N...from an ongoing phase II trial of ZIO-201 (isophos... patients was presented at the,European Society of...07 in Lugano, Switzerland. The abstract entitled, ...coma," was presented by,Rashmi Chugh, MD, a Princi...
...--Jul 9, 2007 - TransPharma Medical,Ltd., a specia...ent,and commercialization of drug products utilizi...technology, announced today,promising results of i...y and pharmacokinetic profile of its ViaDerm-hPTH ... A seven day, repeated dose application, parallel ...
Other Medicine Technology:Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 2TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 3
We have water perfused manometric catheters for esophageal, anorectal and vector volume diagnostic tests. All Medtronic Water Perfused Catheters are made using clear, medical grade PVC tubing. For pr
Each solid state catheter kit below is supplied with adapter cable(s) for Polygraf ID and a Manometric Calibrator.
Each solid state catheter kit below is supplied with adapter cable(s) for Polygraf ID and a Manometric Calibrator.
...dtronic offers a family of single-use products to ...or you. This single-use catheter reduces cross-con...e risk of infection and, because cleaning is elimi...have water perfused manometric catheters for esoph...
Medicine Products: